000			01660 a2200457 4500
005			20250513092602.0
264		0	_c19960821
008			199608s 0 0 eng d
022			_a0250-7005
040			_aNLM _beng _cNLM
100	1		_aSalvati, F
245	0	0	_aCombined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial. _h[electronic resource]
260			_bAnticancer research _c
300			_a1001-4 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAdjuvants, Immunologic _xadverse effects
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCarcinoma, Squamous Cell _xdrug therapy
650	0	4	_aCombined Modality Therapy
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIfosfamide _xadministration & dosage
650	0	4	_aImmunity, Cellular _xdrug effects
650	0	4	_aImmunotherapy
650	0	4	_aInterferon-alpha _xadministration & dosage
650	0	4	_aLeukopenia _xchemically induced
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aThymalfasin
650	0	4	_aThymosin _xadverse effects
700	1		_aRasi, G
700	1		_aPortalone, L
700	1		_aAntilli, A
700	1		_aGaraci, E
773	0		_tAnticancer research _gvol. 16 _gno. 2 _gp. 1001-4
999			_c8684919 _d8684919